Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement

Affiliations

• ¹ Dept of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands Jakko.vaningen@radboudumc.nl.
• ² Division of Pulmonary and Critical Care Medicine, Dept of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
• ³ Respiratory and Intensive Care Unit, University Hospital Amiens, Amiens, France.
• ⁴ EA 4294, AGIR, Jules Verne Picardy University, Amiens, France.
• ⁵ Institute of Medical Microbiology, National Reference Center for Mycobacteria, University of Zurich, Zurich, Switzerland.
• ⁶ National Reference Center for Mycobacteria and Antimycobacterial Resistance, APHP, Hôpitaux universitaires Saint Louis-Lariboisière-Fernand Widal, Bacteriology, Paris, France.
• ⁷ Division of Mycobacterial and Respiratory Infections, National Jewish Health, Denver, CO, USA.
• ⁸ Pulmonary Infectious Disease Section, University of Texas Health Science Center, Tyler, TX, USA.
• ⁹ APHP - Hôpital Lariboisière, Service de Bactériologie, Centre National de Référence des Mycobactéries et de la résistance des Mycobactéries aux Antituberculeux, Paris, France.
• ¹⁰ Université Paris Diderot, Sorbonne Paris Cité, INSERM, IAME UMR1137, Paris, France.
• ¹¹ Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
• ¹² Division of Pulmonary and Critical Care Medicine, Dept of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
• ¹³ Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.
• ¹⁴ German Center for Infection Research (DZIF), Germany.
• ¹⁵ International Health/Infectious Diseases, University of Lübeck, Lübeck, Germany.
• ¹⁶ Dept of Medicine, Karolinska Institute, Stockholm, Sweden.
• ¹⁷ NTM Info & Research, Miami, FL, USA.
• ¹⁸ Dept of Medicine, University of Toronto and University Health Network, Toronto, ON, Canada.
• ¹⁹ Division of Clinical Research, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Tokyo, Japan.
• ²⁰ Pulmonary Branch, National Heart, Lung and Blood Institute, Bethesda, MD, USA.
• ²¹ Service of Infectious Diseases, Bellvitge University Hospital-IDIBELL, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.
• ²² Division of Infectious Diseases and International Health, Duke University Medical Center, Durham, NC, USA.
• ²³ Gallipoli Medical Research Centre, University of Queensland, Brisbane, Australia.
• ²⁴ The Prince Charles and Princess Alexandra Hospitals, Brisbane, Australia.
• ²⁵ Emerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
• ²⁶ Mycobacteria/Nocardia Laboratory, Dept of Microbiology, The University of Texas Health Science Center, Tyler, TX, USA.
• ²⁷ Divisions of Infectious Diseases, Public Health and Preventive Medicine, Oregon Health and Science University, Portland, OR, USA.
• ²⁸ Division of Infectious Diseases, Dept of Medicine II, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.